Answers are grounded in this paper and cite their sources.
Although significant progress in the treatment of breast cancer has been achieved, toxic therapies would not be required if breast cancer could be prevented from developing in the first place. While breast cancer prevention is difficult to study in humans due to long disease latency and stochastic cancer development, transgenic mouse models with 100% incidence and defined mammary tumor onset, provide excellent models for tumor prevention studies. In this study, we used Neu/Erbb2 transgenic mice (MTB-TAN) as a model of human HER2
No takes yet. Share an insight, caveat, or question.
Watson et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: